April 23, 2009

Schumer, Gillibrand Announce $2.5 Million to Improve Medical Research at Cornell

Funds Will Support Research, Treatment Advancements at Cornell University

Washington, D.C. - U.S. Senators Charles Schumer and Kirsten Gillibrand today announced $2.5 million to upgrade and improve resources at Cornell University. The funds will help move forward on critical research and treatment to help improve the lives of all New Yorkers, and are part of the American Recovery and Reinvestment Act, which Senators Schumer and Gillibrand helped pass earlier this year.

"Investing in these institutions makes sense in both the short run and the long run," said Schumer.  "Immediately it will create jobs and advance Cornell's position at the cutting edge of the medical research, while in the long run it will allow our parents and grandparents to live longer, healthier lives."

"It is critical that we invest in the life-saving research at our world class facilities at Cornell," said Senator Gillibrand. "Federal funding for this cutting edge research will help with medical diagnosis and treatment while promoting economic growth in the Finger Lakes Region. During these tough economic times, I will continue to work with Senator Schumer to ensure that New York receives its fair share of federal dollars."

Cornell University will receive $2,000,000 for high-resolution equipment to advance research into the flow, perfusion, diffusion and spectroscopy of human tissue and organs. Cornell will also receive $500,000 cutting edge equipment for Cornell's Proteomics and Mass Spectrometry Core Facility to advance studies for more than two dozen research projects funded by the National Institutes of Health.
 

Senators Schumer and Gillibrand are strong supporters of President Obama's economic plan. The investment will help create or save more than 200,000 jobs in New York, while laying the foundation of future economic growth with critical investments in health care technology, education, infrastructure and renewable energy.